Ovigil 5000IU HCG Human Chorionic Gonadotropin PCT 01/25

HCG in particular cannot be categorized into the three tiers of users (beginner, intermediate, and advanced) as normally outlined and listed in common profiles of the different compounds and drugs. This is due to the fact that HCG is an ancillary drug not particularly used for the purpose of performance enhancement, but instead is utilized to maintain, increase, or restore proper endogenous Testosterone production.

The use of HCG doses during anabolic steroiduse must only be performed under very specific conditions and circumstances, and the following must be made pertinently clear to the reader considering HCG use during anabolic steroid cycles:

HCG should not automatically be utilized during an anabolic steroid cycle unless the cycle is of an extremely long length (12 or more weeks), and/or  the individual is prone to very quick and very severe suppression/shutdown of the HPTA.

Unless an individual exhibits very difficult recovery of endogenous Testosterone production following a cycle, there is no need to utilize HCG during anabolic steroid cycles to maintain testicular function. This is especially true if anabolic steroid cycles are kept short (8 – 10 weeks), as testicular atrophy (if it does occur) will not have remained so for long enough periods of time that there would be difficulty resuming testicular function. If an individual engages in an anabolic steroid cycle of very long cycle lengths (12 weeks or longer), the use of HCG doses every week during the cycle might be necessary due to the extended time in which testicular atrophy will remain. In excessively long cycles, testicular atrophy can result in greater difficulty in hormonal recovery during PCT as a result of desensitization to gonadotropins.

For the purpose of maintaining testicular function during an anabolic steroid cycle, a standard dose of 250 – 500IU of HCG doses administered 1 – 2 times weekly (each injection spaced evenly apart during the week) should be performed if necessary. 500IU should never be exceeded for such a use.

HCG should ideally be utilized as a part of a multi-component PCT protocol whereby HCG is utilized for the first 1 – 2 weeks of PCT, while the other components of the PCT protocol are utilized for the remaining weeks of the total PCT program (4 – 6 weeks total). The best possible addition to HCG in a PCT protocol is Nolvadex (Tamoxifen Citrate), as studies have demonstrated that HCG and Nolvadex utilized together have exhibited a remarkable synergistic effect in terms of stimulating endogenous Testosterone production, and that Nolvadex will actually work to block the desensitization effect on the Leydig cells of the testes caused by high doses of HCG.

HCG within the medical field is primarily administered via intramuscular (IM) injections, although it can also be administered subcutaneously, which has also become just as frequent as IM injections. Studies have found that when intramuscular and subcutaneous injections of HCG were compared, the results were almost the exact same for both, indicating almost no difference between the two[4]. The only difference between the two methods of injection is the difference in the rate of release from the injection site and the time required for peak blood plasma levels to be reached (6 hours for IM, and 16 – 20 hours for subcutaneous). The majority of anabolic steroid users will elect to inject HCG subcutaneously.